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Available online 8 October 2016Increased breast density attributed to collagen I deposition is associated with a 4–6 fold increased risk of devel-
oping breast cancer. Here, we assessed cellular metabolic reprogramming of mammary carcinoma cells in re-
sponse to increased collagen matrix density using an in vitro 3D model. Our initial observations demonstrated
changes in functional metabolism in both normal mammary epithelial cells andmammary carcinoma cells in re-
sponse to changes inmatrix density. Further, mammary carcinoma cells grown in high density collagenmatrices
displayed decreased oxygen consumption and glucose metabolism via the tricarboxylic acid (TCA) cycle com-
pared to cells cultured in low density matrices. Despite decreased glucose entry into the TCA cycle, levels of glu-
cose uptake, cell viability, and ROS were not different between high and low density matrices. Interestingly,
under high density conditions the contribution of glutamine as a fuel source to drive the TCA cycle was signiﬁ-
cantly enhanced. These alterations in functional metabolism mirrored signiﬁcant changes in the expression of
metabolic genes involved in glycolysis, oxidative phosphorylation, and the serine synthesis pathway. This
study highlights the broad importance of the collagen microenvironment to cellular expression proﬁles, and
shows that changes in density of the collagen microenvironment can modulate metabolic shifts of cancer cells.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
Collagen
Matrix density
Metabolism
Breast cancer1. Introduction
Breast cancer is the most commonly diagnosed cancer among
women in the United States, representing 14% of all new cancer diagno-
ses (ACS, 2013). About 1 in 8 women in the United States will be diag-
nosed with invasive breast cancer in their lifetime (ACS, 2013).
Several factors are known to increase the risk for the development of
breast cancer, including but not limited to age, stromal density, obesity,
alcohol consumption, early menarche, late menopause and nulliparity
(Dumitrescu and Cotarla, 2005). Of these, increased breast density is
one of the greatest independent risk factors for the development ofighland Avenue, Madison, WI
. This is an open access article underthe disease (McCormack and dos Santos-Silva, 2006). Increased breast
density as seen by mammography confers a 4–6 fold increased risk of
breast cancer incidence across various subtypes (Boyd et al., 2002;
Boyd et al., 2007). This increase in breast density onmammogram is as-
sociated with an increase in the deposition of extracellular matrix pro-
teins, speciﬁcally collagen I (Guo et al., 2001).
Collagen I is a ﬁbrous, structural component of breast architecture
that provides support to the underlying epithelium. The interactions be-
tween this core ECM component and cell surface integrins not only
plays a role in normal mammary gland function and development, but
also during tumorigenesis (Keely, 2011). Previous studies have shown
that increased stromal collagen deposition enhances mouse mammary
tumor development in vivo (Provenzano et al., 2008). Moreover, in-
creased collagen density in vitro, even in the absence of stromal cells, al-
ters mammary epithelial cell morphology to a more invasive and
proliferative phenotype (Provenzano et al., 2009). These changes arethe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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sion within mammary epithelial cells (Provenzano et al., 2009; Paszek
et al., 2005).
One of the hallmarks of cancer development is alterations in cellular
metabolism(Hanahan andWeinberg, 2011). It has longbeen postulated
that cancer cells upregulate aerobic glycolysis in order to provide the
cancer cells with the building blocks necessary to rapidly proliferate
(Vander Heiden et al., 2009; Warburg, 1956; Warburg et al., 1927). Re-
cently, the role of themitochondria as a biosynthetic “factory” for cancer
cell proliferation has become more apparent (Ahn and Metallo, 2015),
while alterations in metabolism have been found to change depending
on tumor type and the environment around the tumor (Xie et al.,
2014; Choi et al., 2013; Gordon et al., 2015). These studies have
shown that cancer cell metabolism is not a stagnant, predetermined
process but is altered based on the needs of the cell and the conditions
within which the cell is growing. While the majority of studies on the
metabolism of cancer in vitro have been completed in 2D monolayer
cell cultures, a growing number of studies have shown the importance
of the extracellular environment on tumor cell metabolism. A recent
study showed that successful metastasis to various organ sites was de-
pendent upon differential metabolic proﬁles of the same primary
tumor cells (Dupuy et al., 2015). The ﬂux of metabolites through glycol-
ysis and the tricarboxylic acid (TCA) cycle is decreasedwhen breast can-
cer cells are grown in anchorage independent conditions (Grassian
et al., 2011). Additionally, the metabolism of circulating tumor cells is
different than that of primary tumor cells, with a predilection for in-
creased oxidative phosphorylation in circulating tumor cells (Lebleu
et al., 2014). Cellular metabolism is a key ﬁrst responder to changes in
the chemical andmechanical environment (Kamel et al., 2014). Despite
this small but growing data, the direct effect of collagen density on cel-
lular metabolism has not been well established.
In this studywe investigatedwhether themetabolism of cancer cells
is altered in response to changes in collagen ECM density. We sought to
determine the alterations in cellular metabolism in two mammary
breast cancer cell lines in response to changes in collagen matrix densi-
ty. The two cell lines chosen (4T1 and 4T07) arose from the same spon-
taneous mouse mammary tumor and were separated based on
metastatic potential such that 4T1 cells trafﬁc to and formmetastatic le-
sions in the mouse lung, whereas 4T07 cells trafﬁc to the mouse lung
but fail to proliferate, arresting to quiescence (Heppner et al., 2000;
Aslakson and Miller, 1992; Miller et al., 1987). Recent studies using
this clonal cell line panel have shown that metabolic plasticity in re-
sponse to the local microenvironment is greater in the metastatic cell
lines than in the non-metastatic cell lines (Simões et al., 2015; Dupuy
et al., 2015). Surprisingly, we found that the more metastatic 4T1 cells
showed altered metabolism and associated changes in gene expression
in response to changes in extracellular collagen matrix density, while
4T07 cell metabolism was more refractory toward these changes in re-
sponse to changes in density. Our data demonstrate how breast carcino-
ma cells may use adaptable mechanisms to alter their metabolism in
response to changes in the extracellular matrix composition and
density.
2. Materials and Methods
2.1. Cell Lines, Cell Culture
4T1 and 4T07 cell lines were cultured in RPMI 1640media with 10%
FBS. For labeling experiments, cells were cultured in RPMI 1640 media
with isotopically labeled 1,2-13C-glucose (Omicron Biochemicals) or
U-13C-glutamine (Cambridge Isotope Laboratories) replacing the regu-
lar glucose or glutamine at the same concentration. Dialyzed FBS was
used for all labeling experiments. Cells were cultured in a 3D collagen
gel as previously described (Wozniak and Keely, 2005; Burkel et al.,
2016). In short, cells were suspended in a mix of media and a solution
of collagen I (Corning) neutralized with HEPES buffer. This mix (1 mL)was spread evenly over one well of a six well plate and allowed 2 h to
polymerize at 37 °C before being released into media. LD and HD was
2mg/mL and 3.5mg/mL collagen for both cell lines respectively, as pre-
viously deﬁned (Burkel et al., 2016). All cells were cultured at 37 °Cwith
5% CO2. Gels were cultured for 5 days with an initial seeding density of
50,000 cells, with media changed on day 3. For SeaHorse experiment,
microgels were plated as a hanging drop of collagen/cell mixture. Each
droplet contained 30,000 cells andwas poured at an initial volume of ei-
ther 10 μL (LD) or 6 μL (HD) and was cultured for 24 h. The changes in
volume size allowed for contraction of the LD microgel to a size similar
to that of the HDmicrogel after 24 h. For immunoblotting experiments,
cells expressing GFPwere cultured in the samemanner to allow GFP for
use as a loading control.
2.2. Cell Proliferation and Cell Viability
Cell proliferation was determined using a Cyquant NF cell prolifera-
tion assay (ThermoFisher) following manufacturers protocol. In short,
cells were cultured in a 12 well plate in LD or HD collagen in full
media for 5 days. The media was aspirated and replaced with 500 μL
of cyquant solution. Following a 30 minute incubation in 37 °C incuba-
tor, ﬂuorescent intensity was read on a plate reader (Ex 485 nm, Em
538 nm). Cell viability was determined using Calcein AM live cell dye
(ThermoFisher) following manufacturers protocol. Brieﬂy, cells were
cultured in a 12 well plate in LD or HD collagen in full media for
5 days. The media was aspirated and gels were washed 2 times in PBS.
The gels were then incubated in 2 μΜ calcein AM/PBS solution for 1 h
at 37 °C. Following incubation, ﬂuorescent intensity was read on a
plate reader (Ex 485 nm, Em 538 nm).
2.3. Metabolic Assays
ATPwas extracted using a boilingwater extraction technique as pre-
viously described (Yang et al., 2002). In short, 1 mL of boiling water was
added to tubes containing the collagen gels/cells to dissolve the gel and
release cellular ATP. 100 μL of this was used in a 96 well luciferin/lucif-
erase luminescence assay (Sigma). Datawasnormalized by total cellular
DNA after the boiling extraction. Lactate secretion was measured via a
commercially available kit per manufacturer's instructions (Abcam).
Glucose uptakewasmeasured via a commercially available kit perman-
ufacturer's instructions (Eton Biosciences). Glutamine uptake wasmea-
sured via a commercially available kit per manufacturer's instructions
(Sigma). Glucose and glutamine uptakewas found by subtracting levels
in spentmedia from levels in freshmedia stored at 37 °C in the same in-
cubator and for the same time period as spentmedia. All media samples
were collected onmorning of day 5 following full media change on eve-
ning of day 3 (36 h in culture). All three of these media based assays
were normalized to a protein loading control for each individual exper-
iment. Reactive oxygen species were measured using a CellROX green
detection kit (Life technologies), per manufacturer's instructions. Gels
were incubated with the CellROX reagent for 30 min at 37 °C, washed
and counterstained with bisbenzimide, and ﬂuorescent intensity was
measured via a plate reader (CellROX Ex 485 nm, Em 538 nm,
BisBenzimide Ex 355 nm, Em 460 nm). Data was normalized to
bisbenzimide ﬂuorescent intensity. Tert-butyl hydroperoxide (Sigma)
was used as a positive control and added at a concentration of 200 μM
2 h prior to addition of CellROX reagent.
2.4. Hypoxia Indicator
Hypoxia was measured using commercially available ImageIT Hyp-
oxia dye per manufacturer's instructions. In short, ImageIT dye was
added to cells in collagen gels at a concentration of 10 μM for 30 min
at 37 °C. Control gels were then placed in a hypoxia chamber with
100% CO2 ﬂush for 30 min before being imaged. Gels not treated with
hypoxia were imaged after 30 minute incubation with dye in regular
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microscope (Nikon Instruments) equipped with an ORCA-R2 digital
camera (Hamamatsu). Light was passed from a 100-watt mercury arc
lamp through an excitation ﬁlter of 530–560 nm, through a 565 nm di-
chroic ﬁlter to a 590–650 nm emission ﬁlter. Images were acquired
using SlideBook, version 5.0 (Intelligent Imaging Innovations) and proc-
essed using ImageJ software. Mean ﬂuorescence intensity was measure
from3D stacks of images for all cells in a ﬁeld of view and divided by the
mean ﬂuorescence intensity of the background containing no cells.
2.5. SeaHorse Flux Analysis
An XFe96 SeaHorse extracellular ﬂux analyzer was utilized for mea-
surements of oxygen consumption and extracellular acidiﬁcation rate.
Collagen microgels were prepared as described above in full media,
moved to XFe 96well spheroid plate in XF basemedia (SeaHorse Biosci-
ences) with or without glucose supplemented (2 g/L). Glutamine
(Gibco) was injected after 3 baseline readings at a ﬁnal concentration
of 300 mg/L and 10 readings were taken post injection. As a control to
monitor displacement of microgel, Rotenone and Antimycin A were
injected at a ﬁnal concentration of 1 μM, followed by 3 readings to ob-
serve diminishment of oxygen consumption. As each reading was com-
pared to its own initial baseline reading, no additional normalization
was performed and the data is presented as percent change from base-
line. For average basal oxygen consumption and extracellular acidiﬁca-
tion rates (Fig. 2B, C), 3 baselinemeasurements were takenwith cells in
XF base media supplemented with both glucose and glutamine for 1 h
prior to readings. Cells were counted when collagen microgels were
poured, 16 h before assay. From each experiment an additional, ran-
domly chosen microgel was taken for immunoblotting and cell count
was veriﬁed by protein loading control. For the dichloroacetate supple-
mental experiment, cells were cultured 16 h in 10 mM or 25 mM Sodi-
um Dichloroacetate (Sigma), moved into XF base media supplemented
with glucose, glutamine and dichloroacetate for 1 h before 3 baseline
readings were taken.
2.6. RNA Isolation and Microarray Analysis
After culturing cells in HD or LD collagen gels for 5 days, RNA was
isolated via a modiﬁed Trizol extraction. To begin 1 mL gels were
washed 2× with PBS, and dabbed dry on paper towel to remove excess
moisture. 1mLof TRIzol (Life Technologies)was then added, and the gel
was subsequently sheared and homogenized with 18 g needle and sy-
ringe. Once homogenized and solubilized, the protocol was followed ac-
cording to manufacturer's speciﬁcations. The puriﬁed RNAwas assayed
for relative transcript levels with the Affymetrix GeneChip MTA 1.0.
2.7. Immunoblotting
Lysis of cells was carried out as previously described (Wozniak and
Keely, 2005). Reagents used were: turbo-GFP (Evrogen), PDK1, Hexoki-
nase II and Histone H3 (Cell Signaling Technology), pPDH-E1 α
(pSer293) (Millipore), Hif1α (Thermo Scientiﬁc), PDH-E1 α (Abcam)
and Horseradish peroxidase (HRP) – conjugated secondary antibodies
(Jackson ImmunoResearch). All primary antibodies except turbo GFP
were used at dilutions of 1:1000. Turbo GFP and secondary antibodies
were used at a concentration of 1:5000. Densitometry graphs show av-
erage HD over low density fold change (horizontal bar). Individual data
points represent HD over LD fold change of individual experiments.
Error bars represent 95% conﬁdence interval.
2.8. Metabolite Labeling, Extraction and Detection
Cells in collagen gels were cultured in media containing indicated
isotopic tracers for duration of 5 day experiment. Metabolites were ex-
tracted using ice-cold methanol extraction, as described in Maharjanand Ferenci (Maharjan and Ferenci, 2003). Brieﬂy, gels were rinsed
quickly in ice cold PBS at 4C, moved into 1 mL of ice cold 80:20
methanol:H2O and placed in a dry ice/methanol bath for 30min, placed
on ice for 10 min and spun at 14,000 RPM for 10 min at 4 °C. The super-
natant was retained and the pellet was resuspended in 500 μL of 80:20
methanol:dH2O and the process was repeated. The supernatant of both
extractions was ﬁltered using a 3 K centrifugal ﬁlter unit (Amicon) and
then dried using a speed vacuum. Samples were resuspended in water
(LC-MS grade, Sigma), and analyzed by a Thermo Q-exactive Obitrap
mass spectrometer coupled to a UPLC (Dionex 3000). Metabolites
were separated with an ACQUITY UPLC® BEH C18 2.1 × 100 mm col-
umn, 1.7 μm particle size, with a gradient of solvent A (95% H2O, 5%
methanol,10 mM tributylamine, 9 mM acetate, pH = 8.2) and solvent
B (100% methanol) at 0.2 mL/min ﬂow rate. The gradient is: 0 min, 5%
B; 2.5 min, 5% B; 5 min, 20% B; 7.5 min, 20% B; 13 min, 55% B;
15.5 min, 95% B; 18.5 min, 95% B; 19 min, 5% B; 25 min, 5% B. Data
was collected on full scan negative mode at a resolution of 70 K with a
maximum injection time of 40 ms and AGC of 1E6. Data were analyzed
using a Metabolomics Analysis and Visualization Engine (MAVEN)
(Melamud et al., 2010; Clasquin et al., 2012).
2.9. Statistical Analysis
Statistical analysis was performed using Sigma Plot 13.0. For each
sample, only LD vs HDwithin a cell line was compared, no comparisons
were made across cell lines. Normality and equal variance were tested
by the Shapiro-Wilk test and the Brown-Forsythe test respectively. An
unpaired student's t-test (two-tail) was used on all sample passing the
Shapiro-Wilk and Brown-Forsythe test while a Mann-Whitney rank
sum test was performed in instances when these tests failed.
3. Results
3.1. Changes in CollagenMatrix Density Alter the Morphology of Mammary
Carcinoma Cell Lines
Previous studies from our lab have shown that human carcinoma
cell lines display altered morphology in response to changes in collagen
matrix density (Wozniak and Keely, 2005). In 4T1 and 4T07 mouse
mammary cell lines, we noted similar changes in cellular morphology
in response to changes in collagen matrix density (Fig. 1). We observed
that both the 4T1 and 4T07 cell lines formed a differentiated ductal like
morphology when cultured in a low density (LD) collagen matrix. This
differentiation to ductal like morphology was more pronounced in the
4T1 cells than in the 4T07 cells. Moreover, aswe have previously report-
ed, in a LD collagen matrix, these cell lines are able to contract the ma-
trix around them but fail to do so in a HD collagen matrix (Burkel
et al., 2016), similar to what we observed in human carcinoma cell
lines (Wozniak and Keely, 2005). However, when the 4T1 or 4T07 cell
lineswere cultured in a high density (HD) collagenmatrix, we observed
an aberrant morphology characterized by the absence of differentiated
ductal like structures (Fig. 1). In a HD collagen matrix, the 4T1 cells
formed colonies and individual cells, while the 4T07 cells grew largely
as single cells within the matrix.
3.2. Functional Readouts of Cellular Metabolism Are highly Sensitive to
Changes in Collagen Density
To understand how changes in the density of the collagen microen-
vironment impact not only cellularmorphology but also cellularmetab-
olism, we ﬁrst evaluated oxygen consumption, which is an indicator of
mitochondrial respiration, and extracellular acidiﬁcation rates. We
adapted the SeaHorse extracellular ﬂux analyzer capable of analyzing
3D spheroids to work with LD and HD collagen/cell microgels. In both
4T1 and 4T07 cells, oxygen consumption and extracellular acidiﬁcation
rates were the highest when the cells were in a LD collagen microgel
Fig. 1.Changes in cellularmorphology in response to changes in collagenmatrix density. 4T1 and 4T07 cellswere cultured in LD andHD collagenmatrices for 5 days. Ductal-like structures
were observed when cells were grown in a LD (white arrow head) but not a HD collagen matrix.
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matrix than did 4T07 cells. Consistent with these observations, we
also found 4T1 cells had a 2-fold increase in the amount of total cellular
ATPwhen grown in a LD collagen gel compared to a HD gel (Fig. 2c).We
did not observe statistically signiﬁcant changes in the ATP/ADP ratio be-
tween LD or HD collagen matrices in either 4T1 or 4T07 cells, although
the trend was for a higher ATP/ADP ratio in an LD collagen matrix for
both cell lines (Supplemental Fig. 1a). Additionally, we observed similar
changes in OCR and ECAR in two additional cell lines, NMuMG and
MDA-MB-231, with a signiﬁcantly higher level of oxygen consumption
in a LD collagenmicroenvironment and at least a trend toward a higher
ECAR in the same LD collagenmicroenvironment in both cell lines (Sup-
plemental Fig. 2a–d).
These results consistently indicate that the LD collagen microen-
vironment produced the highest cellular energy measurements and
phenotypes. Importantly, we observed no difference in cell
proliferation nor cell viability following 5 days in culture in either a
LD or HD collagen gel for the 4T1 and 4T07 cell lines (Fig. 2d, e).
This indicates that changes in matrix density did not alter changes
in cell proliferation over the course of our experiments for either
cell line.
3.3. Changes in Metabolism Are Not Due to Changes in Reactive Oxygen
Species or Oxygen Availability
Given the changes in oxygen consumption, extracellular acidiﬁcation,
and ATP levels we observed in response to the collagen microenviron-
ment, we next sought to determine the root cause of these differences.
One possible explanation for these changes could be mitochondrial dys-
function or changes in the amount of reactive oxygen species (ROS).
High mitochondrial respiration can lead to increased ROS and cause fur-
thermutagenesiswithin cancer cells. Surprisingly,we foundnodifference
in the level of ROS in response to changes in collagen density in either cell
type (Fig. 2f). The level of ROS in 3D culture, independent of cell type, was
also well below the maximum ROS generated in our positive control
samples using tert-butyl hydroperoxide (Fig. 2f). Moreover, we did notobserve signiﬁcant differences in the NAD+/NADH ratio between 4T1 or
4T07 cells in either a LD or HD matrix (Supplemental Fig. 1b).
An alternative explanation for the differences in metabolic output
could be that the HD collagen gel impedes proper oxygenation and
yields a hypoxic environment for the cells. Utilizing a ﬂuorescent
hypoxia reporter that is quenched by oxygen and thus ﬂuoresces in
hypoxic environments, we investigated whether cells growing in ei-
ther a LD or HD collagen gel experienced hypoxia. Fluorescence
levels for both cell lines were similar between LD and HD gels, and
were notably lower than the ﬂuorescence intensity observed when
cells were imaged in a hypoxia chamber (Fig. 2g). Moreover, we do
not see any differences in protein levels of the transcription factor
Hypoxia Inducible Factor (HIF-1α) bywestern blot even after several
days of normal incubation in either cell line in response to changes in
the collagen microenvironment (Fig. 4b). Collectively, these data
strongly suggest that changes in collagen density do not alter the
production of ROS or oxygen availability for 3D cultured 4T1 or
4T07 breast carcinoma cells.
3.4. A High Density Collagen Microenvironment Decreases Glucose Utiliza-
tion by the TCA Cycle
The changes in oxygen consumption, and ATP level in response to
changes in collagen matrix density potentially suggest general
changes in the utilization of metabolic pathways, especially energy
metabolism. To track glucose metabolism via the TCA cycle, we
labeled 4T1 and 4T07 cells at steady state with 1, 2-13C glucose in
LD and HD collagen gels. Each molecule of 1, 2-13C glucose forms
one unlabeled and one labeled (with two 13C atoms) pyruvate via
glycolysis, which then enters the TCA cycle as unlabeled or doubly
labeled acetyl-coA and undergoes a condensation reaction with
oxaloacetate to form unlabeled or doubly labeled citrate (Fig. 3a).
Surprisingly, incorporation of labeled carbon from glucose into TCA
intermediates was severely diminished in 4T1 cells in a HD collagen
matrix, with under 5% of the citrate containing carbon atoms from
labeled glucose, whereas in LD collagen matrix, ~30% of citrate was
Fig. 2. Functional measures of cellular metabolism are altered in response to increased extracellular collagen matrix density. A and B. Mean basal oxygen consumption and extracellular
acidiﬁcation rate, respectively, for 4T1 and 4T07 cells in LD and HD collagen matrices (N = 15, SD, Signiﬁcance via t-test p b 0.05). Cells were analyzed in collagen spheroids using a
Seahorse Flux analyzer, as described inMethods. C. Total cellular ATP expressed as a fold change ofHD/LD collagen conditions. In both 4T1 and4T07 cells, total cellularATPwas signiﬁcantly
lower in an HD collagenmatrix than in an LDmatrix (normalized to total DNA, n= 3, showing mean fold change±SD, 95% conﬁdence interval (CI) 4T1= 0.39–0.51, 4T07= 0.62–0.75.
p b 0.05 by one-sample t-test.). D. Culture in HD collagen does not cause loss of cell viability. Shown is the percent of living cells in the HD condition normalized to the LD condition, as
determined by Calcein AM. Viable cells were assayed at the end of a 5 day culture. Average viability for each cell line in LD conditions was set as 1. The levels of cell viability seen in
HD conditions was compared to each cell lines' average cell viability for LD (n = 6, ±SD). E. Percent cell proliferation of HD condition over LD condition as determined by Cyquant NF
was assayed at the end of a 5 day culture. Average cell number for each cell line in LD conditions was set as 1. The level of cell proliferation in HD conditions was compared to each cell
lines' average cell viability for LD (n= 5, ±SD). F. Culture of cells in HD collagen does not alter ROS. Level of reactive oxygen species in 4T1 and 4T07 cells in a LD and HD collagenmatrix
in the presence or absence of a positive control to generate ROS, tert-butyl hydroperoxide. No differences were noted between untreated samples in LD or HD. Signiﬁcant differences ob-
served between cells in the same density treated with the positive control (n= 8, mean ﬂuorescence intensity ±SD, P b 0.05 by t-test. Comparison only between same cell type in same
collagen density with orwithout ROS control). G. Effects on oxygen consumption are not likely due to poor oxygen exchange in HD collagen gels. Level of hypoxia indicated by ﬂuorescent
dye that is quenched by the presence of oxygen. Fluorescence of cells over background in 4T1 and 4T07 cells grown in LD andHD collagenmatrix in either standard culture or in a hypoxia
chamber as a positive control (N= 3 independent experiments × 5 ﬁelds of view, mean ﬂuorescence over background value ±SD, P b 0.05 byMann-Whitney rank sum test Comparison
only between same cell type in same collagen density with or without hypoxia control).
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and malate, displayed a great reduction in the labeled fraction
occurring from glucose (Fig. 3c, d). 4T07 cells cultured in HD collagen
showed a similar signiﬁcant, though less profound, decrease in the
percentage of carbon atoms in TCA intermediates derived from
glucose (Fig. 3b, c, d).
While the incorporation of glucose into TCA cycle intermediates
was dramatically decreased in response to a HD collagen microenvi-
ronment, the utilization of glucose through glycolysis was not
signiﬁcantly altered in either cell line, regardless of HD or LD
conditions. No signiﬁcant difference in glucose uptake rate was
found in either 4T1 or 4T07 cells in response to changes in collagen
matrix density (Fig. 3e). Additionally, fructose-1,6-bisphosphate, a
glycolytic intermediate, and lactate, an end product of glycolysis,showed similar labeling patterns across all four conditions (Supple-
mental Fig. 3a,b). Further, we did not observe a signiﬁcant change
in total lactate secretion into the media over 36 h (Fig. 3f). Together,
these results show that a HD collagen matrix speciﬁcally and strong-
ly decreases utilization of carbon derived from glucose in the TCA
cycle. Interestingly, this ﬁnding is much more profound in the 4T1
cells than in the 4T07 cells.
3.5. Metabolic Gene Expression Is Altered in Metastatic 4T1 Cancer Cells in
Response to Changes in Extracellular Collagen Density
Having observed signiﬁcant changes in functional metabolic
readouts and glucose utilization in cells in the HD collagen matrix,
we next sought to determine whether these differences were caused
Fig. 3. Glucose ﬂux through aerobic respiration is altered in response to changes in collagen extracellular matrix density. A. Model depicting carbon atom fates in 1,2-13C glucose labeling
experiment. B, C, D. Contribution of 1,2-13C glucose to the TCA intermediates citrate,α-ketoglutarate, andmalate, respectively.M+2 labeled fractions represents directﬂux of glucose into
TCA cycle. (N= 3, mean± SD, P b 0.05 by t-test). E, F. Levels of lactate secretion and glucose uptake from the samemedia samples (N= 3, mean± SD). (AcCoA – Acetyl CoA,α-KG – α-
ketoglutarate, OAA – Oxaloacetate).
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ations in just a few key metabolic regulators. The greatest changes
in glucose carbon ﬂux and oxygen consumption were found in the
4T1 cells subjected to altered extracellular collagen density, there-
fore we chose to perform a microarray analysis of mRNA to evaluate
changes in gene expression between 4T1 cells in LD and HD collagen
matrices. Alterations in collagen density regulated the expression of
many genes, with a signiﬁcant overlap between this data set and our
previously published microarray in NMuMG cells (Provenzano et al.,
2009). Using a p-value cutoff of 0.01, we found changes in the ex-
pression of numerous genes associated with metabolic pathways.
In a HD collagen matrix compared to a LD matrix, 4T1 cells showed
downregulation of 8 out of 10 genes in glycolysis. Surprisingly, we
observed an upregulation of 7 out of 8 genes of the TCA cycle in a
HD matrix (Fig. 4a), even though we demonstrated above that glu-
cose ﬂux into the TCA cycle was drastically diminished in a HD ma-
trix. Moreover, we noted a downregulation of pyruvate
dehydrogenase kinase 1 and 2 (Fig. 4a). It is important to note that
we did not observe signiﬁcant changes in the expression of lactate
dehydrogenase or the enzymes involved in the pentose phosphate
pathway. We did, however, observe an upregulation in the expres-
sion levels of the enzymes of the serine synthesis pathway and one
carbon metabolism, with the entire pathway being upregulated in
response to a HD collagen matrix in 4T1 cells (Fig. 4a). Additionally,we noted that many of the enzymes involved in oxidative glutamine
metabolism within the TCA cycle were upregulated in a HD collagen
matrix in 4T1 cells (Fig. 4a).
To verify some of these changes in gene expression at the protein
level, we blotted for hexokinase, pyruvate dehydrogenase kinase 1,
and its target, phosphorylated pyruvate dehydrogenase complex in
4T1 cells cultured in a HD collagen matrix (Fig. 4b). All of these protein
levels matched their corresponding expression proﬁle. Importantly, we
did not observe changes in protein expression for PDK1, p-PDH, or
hexokinase in response to changes in collagen matrix density in 4T07
cells (Fig. 4b). This ﬁnding was consistent with our earlier ﬁndings
where we observed little change in ATP production, oxygen consump-
tion and glucose labeling between 4T07 cells in a HD or LD collagenma-
trix. Interestingly, the decrease in phosphorylation of PDH in a HD
matrix compared to a LD matrix in 4T1 cells would suggest higher ﬂux
from pyruvate entering TCA cycle oxidation, thus increased OCR,
which is opposite from our observation. However, treatment of 4T1
cells grown in a LD matrix with 10 mM or 25 mM dichloroacetic acid
(DCA), which inhibits PDK activity, did not signiﬁcantly change OCR or
ECAR, even though we observed a decrease in phosphorylation of PDH
in cells cultured in a LD collagen matrix and treated with either
10 mM or 25 mM DCA (Supplemental Fig. 5a–c). These results suggest
that phosphorylation of PDH is not the control point of glucose oxidative
ﬂux in response to changes in collagen matrix density.
Fig. 4.Microarray analysis reveals alterations in the expression of major pathways of cellular metabolism in response to changes in collagen extracellular matrix density. A. Diagram of
different enzymes in glycolysis, tricarboxylic acid cycle, electron transport chain and serine synthesis pathway regulated by changes in extracellular collagen matrix density in 4T1
cells. Green indicates downregulation in 4T1 cells in a HD collagen matrix while red indicates upregulation of gene in a HD collagen matrix. (N = 5, Fold change N±1.2, and ﬁltered
for signiﬁcance p b 0.01). For Complex I to IV, the number of genes altered in the complex is expressed as a fraction of the total number of genes that contribute to that complex. B.
Representative images for protein immunoblotting for some enzymes in each metabolic pathway. C. Densitometry changes for these immunoblots in 4T1 and 4T07 cells. (HD/LD mean
fold change ±95% conﬁdence interval) (4T1 HD/LD conﬁdence interval for PDK1 = 0.130–0.697, pPDH= 0.241–0.752, Hexokinase II = 0.539–0.809. p b 0/05 by one-sample t-test.).
(PFK1 – Phosphofructokinase 1, PHGDH – 3-Phosphoglycerate dehydrogenase, PSAT – Phosphoserine aminotransferase, PSPH – Phosphoserine phosphatase, SHMT– Serinehydroxymeth-
yl transferase, PDK – Pyruvate dehydrogenase kinase, IDH – Isocitrate dehydrogenase, α-KGDH – α-ketoglutarate dehydrogenase, SCS – Succinyl coA synthetase, SDH – Succinate dehy-
drogenase, MDH –Malate dehydrogenase, GOT – Glutamate oxaloacetate transaminase, PDH – Pyruvate dehydrogenase, HIF – Hypoxia inducible factor).
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tribution to the TCA Cycle
In a HD collagen matrix, the analyzed TCA cycle intermediates
showed a stark decrease in the labeled fraction from 13C-glucose, espe-
cially in 4T1 cells, yet most of the enzymes in the TCA cycle were upreg-
ulated at the mRNA level. The large majority of citrate, α-ketoglutarate
and malate are fully unlabeled from 1,2-13C-glucose (Supplemental Fig.
3c). This suggests a substantial contribution of an additional fuel source
to support the TCA cycle. One possible source is glutamine. Glutamine is
the most abundant free amino acid in the human body (Deberardinis
and Cheng, 2010), and it is necessary to support anabolic processes
that fuel proliferation for some cancer cells (Wise and Thompson,
2010). Glutamine also provides a carbon source for buildup andmainte-
nance of TCA intermediates (Shanware et al., 2011; Deberardinis et al.,
2007). Our gene expression data showed an upregulation in 4T1 cells
inHDcollagenmatrix ofmany enzymes involved in glutaminolysis, sug-
gesting a possible increase in glutamine utilization by the TCA cycle in aHD matrix. Therefore, we traced the utilization of glutamine in our
model using uniformly labeled glutamine (U-13C-glutamine), to deter-
mine if alterations in the density of the collagen microenvironment
changed the contribution of glutamine into the TCA cycle. The 5 carbons
of glutamine enter the TCA cycle as the 5 carbon metabolite, α-
ketoglutarate. From there, themolecule can undergo oxidative metabo-
lism and produce reduced NADH and FADH2. These reduced co-factors
are subsequently oxidized in the electron transport chain leading to
ATP generation. Alternatively, α-ketoglutarate can undergo reductive
carboxylation to generate citrate. This pathway is associated with lipid
synthesis during mitochondrial dysfunction (Mullen et al., 2012;
Metallo et al., 2012). In 4T1 cells embedded in a HDmicroenvironment,
we found a signiﬁcant increase in the labeled fraction of m + 5 α-
ketoglutarate, indicating that a greater proportion of α-ketoglutarate
was coming from labeled glutamine (Fig. 5b). Increased utilization of
glutamine in the TCA cycle in 4T1 cells in HD held throughout the
oxidative glutaminolysis pathway, with increasedm+4 labeledmalate
(Fig. 5c). While we did not notice signiﬁcant differences in glutamine
Fig. 5.Glutamine contribution into the TCA cycle is increased in response to a high density collagen extracellular matrix. A, B, C. Contribution of U-13C glutamine to the TCA intermediates
citrate, α-ketoglutarate, and malate. M + 5 labeled fraction in α-ketoglutarate represents direct ﬂux of glutamine into TCA cycle. M+ 5 citrate labeled fraction is indicative of reductive
glutaminemetabolism.M+4malate labeled fraction is indicative of oxidative glutaminemetabolism (N= 3, mean± SD, P b 0.05 by t-test). D. The percentage of glutamine uptake from
media (spentmedia/fresh media) is not signiﬁcantly different across the conditions (N= 3,mean± SD). E. Percent change in oxygen consumption levels from baseline (ﬁrst 3 measure-
ments) after injection of glutamine (300 mg/L) into medium containing glucose (2 g/L). Rotenone and Antimycin A were injected (1 μM ﬁnal concentration for each) at the end of each
experiment as a control formicrogel displacement. (N=9,mean±SD, P b 0.05 by t-test). Note that only 4T1 cells inHD collagen enhance their respiration upon the addition of glutamine.
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conditions of 4T07 cells had high levels of α-ketoglutarate labeling
from glutamine, similar to that of the 4T1 cells in a HD matrix (Fig.
5b). Surprisingly, reductive glutamine metabolism in both 4T1 and
4T07 cells was increased in HD collagen matrices, as seen by the in-
crease in m + 5 citrate labeling in both conditions (Fig. 5a). We did
not observe a signiﬁcant difference in the amount of glutamine taken
up by 4T1 or 4T07 cells in response to changes in collagen density
(Fig. 5d) as determined over a 36 hour period. These results suggest
that in a HD collagen matrix, 4T1 cells do not alter uptake of glutamine
into the cell, but rather have increased contribution of glutamine into
the TCA cycle, which accounts for the decreased entry of carbon from
glucose into the TCA cycle.
We next sought to understand the ability of cells in different matrix
densities to utilize glucose and/or glutamine to support mitochondrial
respiration. We monitored changes in oxygen consumption in both
4T1 and 4T07 cells in a LD and HDmatrix before and after the injection
of glucose or glutamine into media lacking both these fuel sources.
When adding back glutamine to cells cultured inmedia depleted of glu-
cose and glutamine, all conditions increased oxygen consumption, sug-
gesting that both cell lines in either condition could use glutamine aloneto drive mitochondrial respiration (Supplemental Fig. 4a). The addition
of glucose to cell/microgels cultured in media depleted of both glucose
and glutamine resulted in an increase in extracellular acidiﬁcation but
not oxygen consumption in all conditions (Supplemental Fig. 4b, c), sug-
gesting that starvation from glucose and glutamine led to primarily aer-
obic glycolysis in response to the addition of glucose alone. However,
when we cultured cells in media containing only glucose and then
added glutamine, only the 4T1 cells in the HD collagen microenviron-
ment exhibited increased oxygen consumption over baseline (Fig. 5e).
This suggested that 4T1 cells in a HD collagenmatrix have higher capac-
ity to use glutamine for driving mitochondrial respiration, consistent
with our glucose and glutamine labeling studies as well as our gene ex-
pression data.
4. Discussion
It has long been observed that cancer cells alter their metabolism to
support progression and resiliency (Warburg, 1956; Warburg et al.,
1927; Hanahan and Weinberg, 2011). However, the inﬂuence of the
local extracellular matrix in the tumor microenvironment on cellular
metabolism is not well understood. Here, we report that the density of
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cells.We consistently observe that the cellularmetabolismof twomam-
mary carcinoma cell lines, 4T1 and 4T07, respond signiﬁcantly to chang-
es in the collagen density of their microenvironment. Both cell lines
show decreased oxygen consumption and ATP production in response
to changes in density. The functional metabolism ﬁndings in this study
are not just a peculiarity of the 4T1 clonal cell lines. Indeed, we ﬁnd
changes in OCR and ECAR in response to changes in collagen density
in both a normal mouse mammary gland cell line and a human breast
carcinoma cell line (Supplemental Fig. 2a–d), suggesting that collagen
matrix density alters functional metabolism broadly across mammary
cells.
Strikingly, even though glucose uptake is not affected by the local
collagen microenvironment in 4T1 or 4T07 cells, the fate of the
glucose-derived carbon is regulated by collagen density. In HD colla-
gen, the oxidation of glucose for the TCA cycle is greatly diminished
in both cell lines. There are no differences in glycolysis intermedi-
ates, nor in lactate production, suggesting that the glucose may be
used for other cellular pathways (discussed below). Moreover,
these metabolic changes are not due to changes in cellular prolifera-
tion, ROS levels, or environmental oxygen deprivation in response to
a HD collagen gel. Rather, we ﬁnd global changes in the expression of
several metabolic genes representative of systemic changes to the
cellular signaling network. Interestingly, many of the TCA cycle
genes upregulated in 4T1 cells in an HD matrix are associated with
oxidative glutamine metabolism, a ﬁnding that was conﬁrmed func-
tionally by the increase in OCR seen upon glutamine addition in 4T1
cells (Fig. 5e). Further, we have shown that this decrease in glucose
utilization by the TCA cycle in HD collagen matrices is countered by
an increase in utilization of glutamine for the TCA cycle in this
same condition, suggesting a switching in fuel source for 4T1 cells
in a HD collagen matrix. Together, these ﬁndings demonstrate that
a HD collagen matrix leads to metabolic reprogramming of carcino-
ma cells.
Cancer cells exhibit more metabolic plasticity than their normal
counterparts (Brooks et al., 2015; Scheel and Weinberg, 2011). Such
plasticity allows cancer cells to address the pressures of abnormally
high rates of cell division, transient bouts of oxygen or nutrient depriva-
tion, and migratory behaviors to dissimilar tissues, which allows the
cancer cells to colonize distal organs. A key part of decipheringmetasta-
tic potential could be the sensitivity, responsiveness and plasticity of an
individual cell to the chemical andmechanical cues of the localmicroen-
vironment in which it resides. Two recent studies have added credence
to the idea that metabolic plasticity is important for metastatic poten-
tial, speciﬁcally in the 4T1 clonal cell panel. First, a recent study per-
formed on the 4T1 clonal panel showed that the highly aggressive 4T1
cells were better able to adjust their metabolism to respond to changes
in themicroenvironment than the non-metastatic 67NR cells, which are
derived from the same parental line. In fact the authors reported a con-
tinuum of metabolic plasticity correlated to the metastatic potential of
the cells such that the more metastatic the cell line, the more able that
cell line was to adapt utilization of glycolysis and oxidative phosphory-
lation to its microenvironment (Simões et al., 2015). Moreover, Dupuy
et al. recently demonstrated that highly metastatic 4T1 cells have
increased metabolic plasticity for both glycolysis and oxidative phos-
phorylation compared to their non-metastatic counterparts, 67NR
cells and that this metabolic plasticity directly impacted the metastatic
site seeded by the 4T1 cells (Dupuy et al., 2015). Our results add to
these studies by speciﬁcally testing the importance of collagen matrix
density as a cue to altermetabolism in bothmetastatic 4T1 anddormant
4T07 cells. Moreover, our ﬁnding that matrix density changes the
expression of metabolic genes supports the idea that global metabolic
reprogramming allows cells to adapt to their microenvironment.
Additional experiments are underway to determine if the metabolic
plasticity inﬂuenced by matrix density in 4T1 compared to 4T07 cells
is a key aspect of 4T1 metastatic potential.Underpinning themetabolic plasticity of 4T1 cell lines in response to
changes in collagen density is altered utilization of glucose. Given the
similar levels of glucose derived lactate production, coupled with the
stark decrease in glucose entry into the TCA cycle in 4T1 cells in a HD
collagen matrix, it is intriguing to ask where the carbons from glucose
are being utilized. There are a limited number of possible fates for the
carbons from glucose entering glycolysis. We ﬁnd that all genes in-
volved in the serine synthesis pathway are upregulated at the mRNA
level, while there are no changes in genes for the pentose phosphate
pathway, suggesting the possibility that increased glucose ﬂux is
diverted into the serine synthesis pathway when cells are in HD colla-
gen. This pathwayhas been found to be increased in a variety of cancers,
including breast cancer, and has been shown to enhance the prolifera-
tion and progression of the disease (Locasale, 2013). Thus, an increase
in the serine synthesis pathway would ﬁt with our previous ﬁndings
that cells in a HD collagen matrix proliferate at a greater rate and tend
to bemore aggressive (Provenzano et al., 2008; Provenzano et al., 2009).
A key question that emerges from our studies is what is the carbon
source for the TCA cycle when 4T1 cells are in a HD collagen matrix?
Many transformed cells, including basal breast cancer cells, rely on glu-
tamine for enhanced cell proliferation despite ongoing glycolysis (Kung
et al., 2011; Deberardinis et al., 2007). Indeed, we ﬁnd glutamine to be a
fuel source for the TCA cycle, and observe evidence of both reductive
and oxidative glutamine metabolism. However, a signiﬁcant portion of
the TCA metabolite citrate is not labeled by glucose or glutamine, indi-
cating that glutamine is not the only other source of fuel contributing
to the TCA cycle in 4T1 cells cultured in HD collagen matrices. One in-
triguing possibility is that collagen matrix is being internalized and de-
graded for use as a fuel source in the TCA cycle, explaining the decreased
incorporation of glucose into the TCA cycle in a HD collagenmatrix. Fu-
ture experiments will aim to explore this possibility.
One interesting caveat of our study is the ﬁnding of signiﬁcant
changes in ECAR in response to changes in collagen matrix density for
our SeaHorse analysis of 4T1, 4T07 (Fig. 2b) and NMuMG cells (Supple-
mental Fig. 2b), but no signiﬁcant change in lactate secretion in re-
sponse to changes in collagen matrix density in 4T1 or 4T07 cells.
Importantly, the changes in ECAR or lactate secretion were very small,
whether up or down, in both experiments. However, a recent study
demonstrated that the ECAR readout in the SeaHorse analysis is affected
by CO2 production fromaerobic respiration and thus higher levels of ox-
ygen consumption may skew the ECAR values seen during a SeaHorse
Flux analysis (Mookerjee et al., 2015). This may be the reason why we
see reduced ECAR in HD in Fig. 2B but no change in lactate secretion
as the higher levels of OCR in a LD collagen matrix may be raising the
ECAR in the same condition. Importantly, we do not see a signiﬁcant in-
crease in lactate secretion when cells are in HD and thus increased aer-
obic glycolysis does not explain the lack of glucose in the TCA cycle for
4T1 or 4T07 cells in a HD collagenmicroenvironment. This contribution
of oxygen consumption to total ECAR may also explain why we did not
see signiﬁcant changes in the ECAR of MDA-MB-231 cells in response to
changes in collagen matrix density, as they have a lower basal oxygen
consumption rate and show a smaller, albeit signiﬁcant decrease in ox-
ygen consumption in response to a HD collagen matrix (Supplemental
Fig. 2c–d). Additionally, MDA-MB-231 cells are known to utilize more
aerobic glycolysis and less aerobic respiration than other cell lines, in-
cluding other triple negative breast cancer cell lines (Pelicano et al.,
2014).
Importantly, the basal oxygen consumption rate is reported to be
different across different tumor and normal cell lines based on changes
in various signaling pathways within each cell line (Pelicano et al.,
2014). Moreover, our values for OCR are consistent with previously re-
ported OCR ﬁndings in these and other mammary cell lines (Pelicano
et al., 2014; Rajaram et al., 2015; Xie et al., 2014). Interestingly, we ob-
served changes in both OCR and ECAR inmammary carcinoma cell lines
as well as normal mammary epithelial cell lines (NMuMG), suggesting
that collagen matrix density may broadly regulate metabolism across
155B.A. Morris et al. / EBioMedicine 13 (2016) 146–156themammary gland, not just inmammary carcinoma cell lines. Howev-
er, further studieswould beneeded to deﬁnitively deduce the role of the
collagen extracellular matrix in the metabolism of normal mammary
epithelial cells.
In summary, it is becoming well established that the ECM composi-
tion of the tumor microenvironment drives breast cancer risk and
tumor progression. Our ﬁndings highlight that changes in metabolism
in response to changes in the density of the collagen extracellular envi-
ronment are part of the cellular response to themicroenvironment, and
are likely important to understanding how the extracellular matrix fa-
cilitates metastatic disease.
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